William Fodor, Ph.D. is the Chief Scientific Officer at Biostage, Inc. and has extensive experience in biotechnology and molecular biology. They served as Senior Director at Alexion Pharmaceuticals from 1992 to 2002, where they directed research in cell and tissue engineering, and held various leadership roles at GlyGenix Therapeutics, including Acting Chief Science Officer and CEO. Currently, they are the President of bio*Logical, LLC, providing consulting services, and have been involved with the University of Connecticut as an Associate Professor from 2002 to 2005. Their academic foundation includes a Ph.D. in Molecular Genetics from The Ohio State University, completed in 1988.
This person is not in the org chart
This person is not in any teams
This person is not in any offices